Indian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...

Indian companies achieved better-than-expected profits in the March quarter. Domestic activity was strong, supported by tax cuts and easy m...

There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...

Brokerages maintain a positive outlook on select large-cap pharmaceutical, automobile, and healthcare stocks, citing strong growth prospect...

Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

As India’s GCC ecosystem expands rapidly, enterprise managed workspace providers are emerging as critical enablers of global firms entering...

Despite India's technology ministry warning that prediction markets like Polymarket and Kalshi are illegal, customers in India continue to ...

Branded generics also add significant value to the healthcare ecosystem. They develop and circulate patient education materials. In-patient...

To keep a gauge if a doctor is prescribing drugs manufactured by particular pharmaceutical companies, medical representatives collect weekl...

The additional mandatory declarations such as the address of the manufacturer or packer or importer, the common or generic name of the comm...

The Department of Consumer Affairs makes it mandatory for electronic products to declare certain mandatory declarations through the QR Code...

The upgraded system follows the settlement of the generic crude contract at negative price months ago, which resulted in members long the c...

Hyderabad-based Dr Reddy's Laboratories sprung a surprise on Wednesday when it announced that it will acquire the domestic business of Wock...

"Cipla's portfolio is of a commodity generics type; so this will definitely place it in a strong position in terms of product pipeline in t...

The govt may make it mandatory for all doctors to write the generic or chemical name of drugs they prescribe, a move that can cut medicine ...

Mukesh Ambani's Reliance Pharma could vie with global giants Mylan and Ranbaxy in bidding for Shasun's Rs 400-crore API business. Bring hom...

Ranbaxy Laboratories is about to enter into a 10-year co-marketing agreement with Jupiter Bioscience to tap the $6-billion global peptide p...